Cargando…

Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies

Mostrar otras versiones (1)

SARS-CoV-2 (Severe Acute Respiratory Syndrome), an etiolating agent of novel COVID-19 (coronavirus 2019) pandemic, rapidly spread worldwide, creating an unprecedented public health crisis globally. NSP5, the main viral protease, is a highly conserved protein, encoded by the genome of SARS-CoV-2 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yashvardhini, Niti, Kumar, Amit, Jha, Deepak Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier España, S.L.U. 2022
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472678/ http://dx.doi.org/10.1016/j.vacune.2022.08.001

Ejemplares similares

Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies
por: Yashvardhini, Niti, et al.
Publicado: (2022)

Genome sequence analysis of nsp15 from SARS-CoV-2
por: Yashvardhini, Niti, et al.
Publicado: (2022)

Immunoinformatics Identification of B- and T-Cell Epitopes in the RNA-Dependent RNA Polymerase of SARS-CoV-2
por: Yashvardhini, Niti, et al.
Publicado: (2021)

Identification and characterization of mutations in the SARS-CoV-2 RNA-dependent RNA polymerase as a promising antiviral therapeutic target
por: Yashvardhini, Niti, et al.
Publicado: (2021)

Rejuvenating impact of COVID-19 lockdown on major environmental parameters: an Indian perspective
por: Jha, Deepak Kumar, et al.
Publicado: (2022)

The status of COVID-19 vaccines in India: A review
por: Jha, Deepak Kumar, et al.
Publicado: (2023)

Positive impact of COVID-19 induced lockdown on the environment of India’s national capital, Delhi
por: Yashvardhini, Niti, et al.
Publicado: (2021)

Identification of novel mutations in the methyltransferase complex (Nsp10-Nsp16) of SARS-CoV-2
por: Azad, Gajendra Kumar
Publicado: (2020)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease
por: Milligan, Jennifer C., et al.
Publicado: (2021)

SARS-CoV-2 main protease Nsp5 cleaves and inactivates human tRNA methyltransferase TRMT1
por: Lu, Jia-Li, et al.
Publicado: (2023)

A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods
por: Singh, Ekampreet, et al.
Publicado: (2020)

Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase
por: Mirza, Muhammad Usman, et al.
Publicado: (2020)

Cleavage of the selective autophagy receptor SQSTM1/p62 by the SARS-CoV-2 main protease NSP5 prevents the autophagic degradation of viral membrane proteins
por: Zhang, Yabin, et al.
Publicado: (2022)

Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors
por: Kumar, Prateek, et al.
Publicado: (2019)

Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication
por: Lin, Lin, et al.
Publicado: (2023)

Scalable Inhibitors of the Nsp3–Nsp4 Coupling in SARS-CoV-2
por: Azizogli, Abdul-Rahman, et al.
Publicado: (2023)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Tuning proton transfer thermodynamics in SARS-Cov-2 main protease: implications for catalysis and inhibitor design
por: Zanetti-Polzi, Laura, et al.
Publicado: (2020)

Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
por: Grover, Vishakha, et al.
Publicado: (2022)

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors
por: Kim, Hoshin, et al.
Publicado: (2022)

Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
por: Bhardwaj, Vijay Kumar, et al.
Publicado: (2021)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
por: van de Sand, Lukas, et al.
Publicado: (2021)

The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression
por: Bujanic, Lucija, et al.
Publicado: (2022)

SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms
por: Vazquez, Christine, et al.
Publicado: (2021)

Identification of mutation resistance coldspots for targeting the SARS‐CoV2 main protease
por: Krishnamoorthy, Navaneethakrishnan, et al.
Publicado: (2021)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
por: Yu, Wei, et al.
Publicado: (2021)

Multi-targeting approach for nsp3, nsp9, nsp12 and nsp15 proteins of SARS-CoV-2 by Diosmin as illustrated by molecular docking and molecular dynamics simulation methodologies
por: Kumar, Sumit, et al.
Publicado: (2021)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
por: Tripathi, Praveen Kumar, et al.
Publicado: (2020)

Crystal structure of SARS-CoV-2 nsp10/nsp16 2′-O-methylase and its implication on antiviral drug design
por: Lin, Sheng, et al.
Publicado: (2020)

Characterization of the SARS-CoV-2 ExoN (nsp14(ExoN)–nsp10) complex: implications for its role in viral genome stability and inhibitor identification
por: Baddock, Hannah T, et al.
Publicado: (2022)

Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design
por: Zanetti-Polzi, Laura, et al.
Publicado: (2021)

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
por: Kirchdoerfer, Robert N., et al.
Publicado: (2019)

Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication
por: Wilamowski, Mateusz, et al.
Publicado: (2021)

SARS-CoV-2 NSP1 C-terminal (residues 131–180) is an intrinsically disordered region in isolation
por: Kumar, Amit, et al.
Publicado: (2021)

Fragment-based inhibitor design for SARS-CoV2 main protease
por: Andola, Priyanka, et al.
Publicado: (2022)

The Effect of Point Mutations on Structure and Dynamics of SARS-CoV-2 Main Protease Mutants
por: Diessner, Elizabeth M., et al.
Publicado: (2021)

Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
por: Padhi, Aditya K., et al.
Publicado: (2022)

Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase
por: Benoni, Roberto, et al.
Publicado: (2021)

The role of herbal plants in the inhibition of SARS-CoV-2 main protease: A computational approach
por: Srivastava, Ambrish Kumar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o305t2a4pc75vrckkapoh17d4m